• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.

作者信息

Thonhofer R, Gaugg M, Kriessmayr M, Neumann H J, Erlacher L

出版信息

Ann Rheum Dis. 2005 Jul;64(7):1098-9. doi: 10.1136/ard.2004.026252.

DOI:10.1136/ard.2004.026252
PMID:15958773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1755549/
Abstract
摘要

相似文献

1
Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.一名血清阳性类风湿关节炎患者在停用英夫利昔单抗-甲氨蝶呤治疗后边缘区B细胞淋巴瘤自发缓解。
Ann Rheum Dis. 2005 Jul;64(7):1098-9. doi: 10.1136/ard.2004.026252.
2
Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.在一名接受英夫利昔单抗/甲氨蝶呤治疗的类风湿关节炎患者中，单独停用英夫利昔单抗后淋巴瘤消退。
Rheumatology (Oxford). 2011 Apr;50(4):808-10. doi: 10.1093/rheumatology/keq417. Epub 2010 Dec 22.
3
Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature.类风湿关节炎患者停用甲氨蝶呤后低度B细胞非霍奇金淋巴瘤自发缓解：病例报告及文献复习
Br J Haematol. 2002 Aug;118(2):567-8. doi: 10.1046/j.1365-2141.2002.03619.x.
4
[Cutaneous lymphoma associated with methotrexate in a patient with rheumatoid arthritis].[类风湿关节炎患者中与甲氨蝶呤相关的皮肤淋巴瘤]
Farm Hosp. 2018 Jan 1;42(1):35-36. doi: 10.7399/fh.10898.
5
[Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].[病例报告：一名类风湿关节炎患者接受甲氨蝶呤和英夫利昔单抗治疗后发生难治性贫血伴原始细胞过多]
Reumatismo. 2006 Jan-Mar;58(1):59-61.
6
Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.类风湿关节炎甲氨蝶呤治疗期间出现的原发性皮肤B细胞淋巴瘤
J Rheumatol. 2000 Jun;27(6):1546-9.
7
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎。类风湿关节炎联合治疗抗肿瘤坏死因子试验研究组。
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
8
Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.一种生物制剂对甲氨蝶呤相关B细胞淋巴瘤治疗后类风湿关节炎患者的影响：一例报告
BMC Res Notes. 2014 Apr 11;7:229. doi: 10.1186/1756-0500-7-229.
9
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.类风湿关节炎患者采用甲氨蝶呤单药治疗以及英夫利昔单抗联合甲氨蝶呤治疗并达到不同疾病活动状态时的影像学改变：缓解和肿瘤坏死因子阻断的影响
Ann Rheum Dis. 2009 Jun;68(6):823-7. doi: 10.1136/ard.2008.090019. Epub 2008 Jul 1.
10
[Infliximab in the treatment of rheumatoid arthritis].[英夫利昔单抗治疗类风湿关节炎]
Nihon Rinsho. 2002 Dec;60(12):2378-83.

引用本文的文献

1
Spontaneous Regression of Cranial Vault Lymphoma: A Case Report.颅骨淋巴瘤的自发消退：一例报告
Cureus. 2025 Jul 7;17(7):e87472. doi: 10.7759/cureus.87472. eCollection 2025 Jul.
2
Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma.淋巴瘤诊断和治疗后英夫利昔单抗用于治疗重度肛周克罗恩病的安全使用。
Clin J Gastroenterol. 2018 Feb;11(1):48-52. doi: 10.1007/s12328-017-0802-8. Epub 2017 Nov 22.
3
Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.免疫抑制治疗下类风湿关节炎、银屑病关节炎和强直性脊柱炎患者的恶性肿瘤风险：单中心经验。
Intern Emerg Med. 2016 Feb;11(1):31-40. doi: 10.1007/s11739-015-1270-0. Epub 2015 Jun 23.
4
Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.抗肿瘤坏死因子药物相关淋巴瘤信息来源：已发表病例报告与法国药物警戒系统报告病例比较
Drug Saf. 2011 Jul 1;34(7):577-85. doi: 10.2165/11590200-000000000-00000.
5
A practical approach to screening psoriasis patients for therapy with biologic agents.一种筛查银屑病患者以使用生物制剂进行治疗的实用方法。
J Clin Aesthet Dermatol. 2008 Sep;1(3):50-4.
6
A practical approach to monitoring patients on biological agents for the treatment of psoriasis.一种监测接受生物制剂治疗银屑病患者的实用方法。
J Clin Aesthet Dermatol. 2010 Aug;3(8):20-6.
7
Pulmonary non-Hodgkin's lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis.在长期甲氨蝶呤治疗类风湿关节炎期间发展出了肺非霍奇金淋巴瘤。
Rheumatol Int. 2012 Nov;32(11):3639-42. doi: 10.1007/s00296-010-1496-0. Epub 2010 Apr 18.
8
Is there truly a risk of lymphoma from biologic therapies?生物疗法真的存在引发淋巴瘤的风险吗？
Dermatol Ther. 2009 Sep-Oct;22(5):418-30. doi: 10.1111/j.1529-8019.2009.01258.x.
9
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.抗 TNF 治疗患者的淋巴瘤：前瞻性法国 RATIO 注册研究 3 年结果。
Ann Rheum Dis. 2010 Feb;69(2):400-8. doi: 10.1136/ard.2009.117762. Epub 2009 Oct 14.
10
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.治疗幼年特发性关节炎的生物疗法：来自成人和儿童治疗经验的启示。
Biologics. 2008 Jun;2(2):229-52. doi: 10.2147/btt.s2210.